Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity.

von Eckardstein, A; Schmiddem, K; Hövels, A; Gülbahçe, E; Schuler-Lüttmann, S; Elbers, J; Helmond, F; Bennink, H J; Assmann, G

von Eckardstein, A; Schmiddem, K; Hövels, A; Gülbahçe, E; Schuler-Lüttmann, S; Elbers, J; Helmond, F; Bennink, H J; Assmann, G.

Affiliation

von Eckardstein A; Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany. vonecka@uni-muenster.de

Atherosclerosis ; 159(2): 433-9, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11730824

Subject(s)

Anabolic Agents/administration & dosage; Apolipoprotein A-I/blood; Cholesterol, HDL/blood; Coronary Artery Disease/diagnosis; Esterases/metabolism; Norpregnenes/therapeutic use; Aged; Apolipoprotein A-II/blood; Aryldialkylphosphatase; Cholesterol/metabolism; Coronary Artery Disease/enzymology; Double-Blind Method; Female; Hormone Replacement Therapy/methods; Humans; Middle Aged; Postmenopause; Reference Values; Statistics, Nonparametric

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Apolipoprotein A-I / Esterases / Anabolic Agents / Cholesterol, HDL / Norpregnenes Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Atherosclerosis Year: 2001 Document type: Article Affiliation country: Germany Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links